No benefit of β-blockers after myocardial infarction with preserved ejection fraction

Nature Reviews Cardiology, Published online: 22 April 2024; doi:10.1038/s41569-024-01030-0In the REDUCE-AMI trial, the use of β-blockers in patients with acute myocardial infarction (MI) who have undergone early coronary angiography and have a preserved left ventricular ejection fraction did not reduce the risk of death or new MI compared with no β-blocker use.
Source: Nature Reviews Cardiology - Category: Cardiology Authors: Source Type: research